Answers are grounded in this paper and cite their sources.
Purpose: The aim of this study is to assess the quality of sleep and contributing factors in treated patients with schophrenia. Materials and methods:The sleep quality of 411 subjects in treatment for schizophrenia was assessed.A cross-sectional study design was used to determine mediating factors.A consecutive sampling technique was used for recruitment.The Pittsburgh Sleep Quality Index (PSQI) was used to assess outcome variables, and the positive and negative syndrome scale (PANSS) and the four-item Morisky-Green test (MGT) was used for symptom severity and medication adherence.Logistic regression analysis was used to determine factor association and the adjusted odds ratio (AOR) and a p-value < 0.05 determined statistical significance.Results: More than half of the patients were poor sleepers.Sleep determinants were: a) urban residence AOR=3.08 [2.57, 8.12], b) family size ≥6 AOR=2.72 [1.38, 5.08], c) current khat use AOR=2.30[1.22, 4.31], d) low antipsychotics adherence AOR=6.23 [3.61, 10.75], e) positive and negative syndrome scale (PANSS) for positive symptoms greater than mean AOR=2.99 [1.69, 5.30] and PANSS for general symptoms greater than mean AOR=4.22 [2.22, 8.05].These were all significantly associated with sleep quality on multiple logistic regressions.Conclusion: There is a high prevalence of poor sleep quality among schizophrenia patients and risk factors are known.It is time to address these factors clinically to ensure better health for this population.
No takes yet. Share an insight, caveat, or question.
Dule et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: